H. R. 467, 117th Congress — To Amend the Families First Coronavirus Response Act and the CARES Act
Summary
H. R. 467 was introduced in the House of Representatives on January 25, 2021, by Gonzalez of Ohio (for himself and Spanberger). It is a bill to amend the Families First Coronavirus Response Act and the CARES Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage, without cost sharing, of certain COVID–19 antibody treatments. Section 2 adds items consisting of monoclonal antibody infusions needed for treatment of COVID–19 in individuals with positive COVID–19 test results, including services for administration.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
- Issuer
- Congressional materials
- Document type
- Bills Bills 117Hr467Ih Bills 117Hr467Ih
- Case
- Bills Bills 117Hr467Ih Bills 117Hr467Ih
Cite this document
“H. R. 467, 117th Congress — To Amend the Families First Coronavirus Response Act and the CARES Act.”
Original at www.govinfo.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/bills-bills-117hr467ih-bills-117hr467ih/
, SHA-256 5e9014d0f2d32e39ff55bdfdd0e920f7ef1f25d6c7d155c27a58cafdcc0afb50.Full text
I
117TH CONGRESS
1ST SESSION
H. R. 467
To amend the Families First Coronavirus Response Act and the CARES
Act to require group health plans and health insurance issuers offering
group or individual health insurance coverage to provide coverage, with-
out cost sharing, of certain COVID–19 antibody treatments.
IN THE HOUSE OF REPRESENTATIVES
JANUARY 25, 2021
Mr. GONZALEZ of Ohio (for himself and Ms. SPANBERGER) introduced the fol-
lowing bill; which was referred to the Committee on Energy and Com-
merce, and in addition to the Committees on Ways and Means, and Edu-
cation and Labor, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall within
the jurisdiction of the committee concerned
A BILL
To amend the Families First Coronavirus Response Act and
the CARES Act to require group health plans and health
insurance issuers offering group or individual health in-
surance coverage to provide coverage, without cost shar-
ing, of certain COVID–19 antibody treatments.
1 Be it enacted by the Senate and House of Representa-
2 tives of the United States of America in Congress assembled,
3 SECTION 1. SHORT TITLE.
pamtmann on DSKBC07HB2PROD with BILLS
4 This Act may be cited as the ‘‘Protecting Patient Ac-
5 cess to Lifesaving COVID–19 Drugs Act of 2021’’.
VerDate Sep 11 2014 16:10 Feb 13, 2021 Jkt 019200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H467.IH H467
2
1 SEC. 2. REQUIRING GROUP HEALTH PLANS AND HEALTH
2 INSURANCE ISSUERS OFFERING GROUP OR
3 INDIVIDUAL HEALTH INSURANCE COVERAGE
4 TO PROVIDE COVERAGE, WITHOUT COST
5 SHARING, OF CERTAIN COVID–19 ANTIBODY
6 TREATMENTS.
7 (a) IN GENERAL.—Section 6001(a) of the Families
8 First Coronavirus Response Act (42 U.S.C. 1320b–5 note)
9 is amended—
10 (1) in the matter preceding paragraph (1), by
11 inserting ‘‘(or, in the case of items and services de-
12 scribed in paragraph (3), beginning on or after the
13 date of the enactment of the Protecting Patient Ac-
14 cess to Lifesaving COVID–19 Drugs Act of 2021)’’
15 after ‘‘this Act’’; and
16 (2) by adding at the end the following new
17 paragraph:
18 ‘‘(3) Items consisting of monoclonal antibody
19 infusions (as specified by the Secretary) approved,
20 cleared, or otherwise authorized by the Food and
21 Drug Administration needed for the treatment of
22 COVID–19 in individuals with positive COVID–19
23 test results, including services for the administration
24 of such items.’’.
pamtmann on DSKBC07HB2PROD with BILLS
•HR 467 IH
VerDate Sep 11 2014 16:10 Feb 13, 2021 Jkt 019200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H467.IH H467
3
1 (b) REIMBURSEMENT FOR TREATMENTS.—Section
2 3202 of the CARES Act (42 U.S.C. 256b note) is amend-
3 ed—
4 (1) in the header, by inserting ‘‘AND ANTI-
5 BODY TREATMENTS’’ after ‘‘TESTING’’;
6 (2) in subsection (a), in the matter preceding
7 paragraph (1), by inserting ‘‘or antibody treatment,
8 as applicable,’’ after ‘‘diagnostic testing’’; and
9 (3) in subsection (b)—
10 (A) in the header, by inserting ‘‘AND ANTI-
11 BODY TREATMENTS’’ after ‘‘TESTING’’; and
12 (B) in paragraph (1)—
13 (i) by inserting ‘‘or antibody treat-
14 ment’’ after ‘‘diagnostic test’’; and
15 (ii) by inserting ‘‘or treatment (in-
16 cluding the administration of such treat-
17 ment)’’ after ‘‘such test’’.
Æ
pamtmann on DSKBC07HB2PROD with BILLS
•HR 467 IH
VerDate Sep 11 2014 16:10 Feb 13, 2021 Jkt 019200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\H467.IH H467
File and source
- File
- BILLS_bills-117hr467ih_bills-117hr467ih.pdf
- Size
- 232,565 bytes
- SHA-256
- 5e9014d0f2d32e39ff55bdfdd0e920f7ef1f25d6c7d155c27a58cafdcc0afb50
- Original
- www.govinfo.gov